Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan
· Delayed Price · Currency is TWD 21.40
+0.10 (0.47%)
Apr 29, 2026, 11:51 AM CST
Bioray Biotech Revenue
Bioray Biotech had revenue of 114.14M TWD in the half year ending June 30, 2025, with 21.35% growth. This brings the company's revenue in the last twelve months to 230.06M, up 25.32% year-over-year. In the year 2024, Bioray Biotech had annual revenue of 201.71M with 5.15% growth.
Revenue (ttm)
230.06M
Revenue Growth
+25.32%
P/S Ratio
2.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
633.12M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Golden Biotechnology | 44.58M |
| UniPharma | 88.44M |
| Mediera | 229.85M |
| Original BioMedicals | 381.00K |
| Prince Pharmaceutical | 1.06B |
| Anxo Pharmaceutical | 883.22M |
| Excelsior Biopharma | 898.26M |
| DV Biomed | 794.18M |